{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:06:53Z","timestamp":1791875213908,"version":"4.3.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>Treatment of people living with human immunodeficiency virus (HIV) (PLHIV) is monitored using plasma HIV viral load levels and CD4 counts. Patients with either immunological nonresponse (virological suppression achieved) or virological nonresponse (immune reconstitution achieved) are termed as having a discordant response. These patients are at higher risk for acquired immunodeficiency syndrome (AIDS)-related infections\/diseases\/neoplasms, non-AIDS-related illnesses (cardiovascular, neurological, renal, hepatic diseases), and all-cause death. This study was conducted to assess the prevalence of immunovirological discordance among PLHIV after completion of at least 1 year of combination antiretroviral therapy (cART) at an antiretroviral therapy (ART) plus center in India and analyze contributory factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study was a retrospective study of PLHIV receiving cART at the ART plus clinic in Western India from January 18 to December 21. Four hundred and ninety-six patients were studied based on sample size calculated and assessed for CD4 and viral load response at 0, 6, and 12 months of ART.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 496 patients, 48 patients (9.7%) had immunovirological discordance. Out of them, 36 patients (75%) had a virological response (immunological nonresponse) and 12 (25%) patients had an immunological response (virological nonresponse). The factors contributing to immunological nonresponse were as follows \u2013 low baseline CD4 levels (&lt;100 cells) (36.1%), adherence &lt;95% (33.3%), presence of opportunistic infections (16.6%), and failure on first-line therapy (11.1%). Other factors noted included higher baseline viral load (2.7%), chronic kidney disease (5.5%), and chronic hepatitis B virus co-infection (5.5%). Virological nonresponse was associated with poor adherence to therapy &lt;95% (33%) and failure of first-line regimen (33%). Opportunistic infections were noted among 33% of patients and 8.3% of patients were found to have higher baseline viral load.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation and Conclusion:<\/jats:title>\n                    <jats:p>Immunovirological discordance is an important factor influencing response to cART and is associated with many complications such as AIDS and non-AIDS-related events and even death. Improved adherence and timely identification and management of opportunistic infections are measures that are beneficial in reducing the incidence of immunovirological discordance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijstd.ijstd_121_22","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T03:01:40Z","timestamp":1685934100000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Immunovirological discordance among people living with human immunodeficiency virus at a center in Western India"],"prefix":"10.4103","volume":"44","author":[{"given":"Mayank","family":"Kacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Vashisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil S.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20240831","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-4-20240831","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/QAD.0000000000000243","article-title":"Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy","volume":"28","author":"May","year":"2014","journal-title":"AIDS"},{"key":"R5-4-20240831","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"R7-4-20240831","doi-asserted-by":"crossref","first-page":"18194","DOI":"10.7448\/IAS.15.6.18194","article-title":"Immuno-virological discordance is associated with a higher frequency of AIDS, severe non-AIDS, and death","volume":"15","author":"Zoufaly","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"R8-4-20240831","doi-asserted-by":"crossref","first-page":"e0156099","DOI":"10.1371\/journal.pone.0156099","article-title":"Discordant immune response with antiretroviral therapy in HIV-1: A systematic review of clinical outcomes","volume":"11","author":"Kelly","year":"2016","journal-title":"PLoS One"},{"key":"R10-4-20240831","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12879-021-06206-4","article-title":"Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia","volume":"21","author":"Hailu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R11-4-20240831","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/S0036-46652011000600001","article-title":"Prevalence of discordant immunologic and virologic responses in patients with AIDS under antiretroviral therapy in a specialized care center in Brazil","volume":"53","author":"Casotti","year":"2011","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"R12-4-20240831","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-13-113","article-title":"Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria","volume":"13","author":"Anude","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R13-4-20240831","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0253-7184.85412","article-title":"Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy","volume":"32","author":"Prabhakar","year":"2011","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"R15-4-20240831","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/ciu038","article-title":"Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery","volume":"58","author":"Engsig","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R16-4-20240831","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4102\/sajhivmed.v13i4.110","article-title":"Risk factors for discordant immune response among HIV-infected patients initiating antiretroviral therapy: A retrospective cohort study","volume":"13","author":"Muzah","year":"2012","journal-title":"South Afr J HIV Med"},{"key":"R17-4-20240831","doi-asserted-by":"crossref","first-page":"e0159446","DOI":"10.1371\/journal.pone.0159446","article-title":"Discordant treatment responses to combination antiretroviral therapy in Rwanda: A prospective cohort study","volume":"11","author":"Kayigamba","year":"2016","journal-title":"PLoS One"},{"key":"R18-4-20240831","doi-asserted-by":"crossref","first-page":"e31161","DOI":"10.1371\/journal.pone.0031161","article-title":"Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected Zulu\/Xhosa in South Africa","volume":"7","author":"Julg","year":"2012","journal-title":"PLoS One"},{"key":"R19-4-20240831","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12879-022-07109-8","article-title":"Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso","volume":"22","author":"Bazi\u00e9","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R20-4-20240831","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/QAI.0b013e318042e1c3","article-title":"Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: The antiretroviral therapy in low-income countries (ART-LINC) collaboration","volume":"45","author":"Tuboi","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-4-20240831","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.qai.0000182847.38098.d1","article-title":"Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy","volume":"40","author":"Moore","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-4-20240831","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1586\/1744666X.2013.842897","article-title":"Immunodiscordant responses to HAART \u2013 Mechanisms and consequences","volume":"9","author":"Massanella","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"R23-4-20240831","doi-asserted-by":"crossref","first-page":"670957","DOI":"10.1155\/2012\/670957","article-title":"Incomplete immune recovery in HIV infection: Mechanisms, relevance for clinical care, and possible solutions","volume":"2012","author":"Gaardbo","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"R24-4-20240831","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","article-title":"Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders","volume":"107","author":"Yang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"R25-4-20240831","doi-asserted-by":"crossref","first-page":"e27624","DOI":"10.1097\/MD.0000000000027624","article-title":"Factors associated with immunological and virological discordant responses to highly active antiretroviral therapy among adult HIV positive individuals in Ethiopia: A cross-sectional study","volume":"100","author":"Manaye","year":"2021","journal-title":"Medicine (Baltimore"},{"key":"R26-4-20240831","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/aid.2012.0192","article-title":"Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment","volume":"29","author":"Ku","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R27-4-20240831","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5493\/wjem.v2.i4.70","article-title":"Immunology of tuberculosis","volume":"2","author":"Zhang","year":"2012","journal-title":"World J Exp Med"},{"key":"R28-4-20240831","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/695852","article-title":"The absence of CD4+T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: Clinical risk, immunological gaps, and therapeutic options","volume":"48","author":"Gazzola","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R29-4-20240831","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7883\/yoken.JJID.2014.062","article-title":"Factors associated with immunological discordance in HIV-infected patients receiving antiretroviral therapy with complete viral suppression in a resource-limited setting","volume":"68","author":"Mingbunjerdsuk","year":"2015","journal-title":"Jpn J Infect Dis"}],"container-title":["Indian Journal of Sexually Transmitted Diseases and AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijstd.ijstd_121_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:10:24Z","timestamp":1787760624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijstd.ijstd_121_22"}},"subtitle":["A retrospective study"],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijstd.ijstd_121_22","relation":{},"ISSN":["2589-0557"],"issn-type":[{"value":"2589-0557","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}